Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SPFPLAS PHARMACIE CLAUDE BERNARD : revenue, balance sheet and financial ratios

SPFPLAS PHARMACIE CLAUDE BERNARD is a French company founded 5 years ago, specialized in the sector Fonds de placement et entités financières similaires. Based in PARIS (75019), this company of category PME shows in 2022 a net income positive of 98 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SPFPLAS PHARMACIE CLAUDE BERNARD (SIREN 883460537)
Indicator 2022 2021
Revenue N/C N/C
Net income 97 768 € 87 207 €
EBITDA -4 862 € -8 466 €
Net margin N/C N/C

Revenue and income statement

In 2022, SPFPLAS PHARMACIE CLAUDE BERNARD generates positive net income of 98 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2021-2022: 87 k€ -> 98 k€.

EBITDA (2022) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-4 862 €

EBIT (2022) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-4 862 €

Net income (2022) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

97 768 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 398%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 20%. Low autonomy: the company heavily depends on external financing (banks, suppliers). Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 11.5 years of cash flow to repay all financial debt. Beyond 7 years, banks generally consider credit risk as high.

Debt ratio (2022) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

397.925%

Financial autonomy (2022) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

19.936%

Repayment capacity (2022) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

11.52

Solvency indicators evolution
SPFPLAS PHARMACIE CLAUDE BERNARD

Sector positioning

Debt ratio
397.93 2022
2021
2022
Q1: 0.04
Med: 14.14
Q3: 118.39
Average

In 2022, the debt ratio of SPFPLAS PHARMACIE CLAUDE ... (397.93) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
19.94% 2022
2021
2022
Q1: 18.05%
Med: 62.02%
Q3: 91.75%
Average

In 2022, the financial autonomy of SPFPLAS PHARMACIE CLAUDE ... (19.9%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
11.52 years 2022
2021
2022
Q1: -0.0 years
Med: 0.04 years
Q3: 3.93 years
Average

In 2022, the repayment capacity of SPFPLAS PHARMACIE CLAUDE ... (11.52) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 0.00. Alert: short-term debt exceeds current assets. Risk of payment difficulties without cash reinforcement.

Liquidity ratio (2022) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

0.0

Interest coverage (2022) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

-130.646

Liquidity indicators evolution
SPFPLAS PHARMACIE CLAUDE BERNARD

Sector positioning

Liquidity ratio
0.0 2022
2021
2022
Q1: 118.61
Med: 637.87
Q3: 4243.78
Average

In 2022, the liquidity ratio of SPFPLAS PHARMACIE CLAUDE ... (0.00) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
-130.65x 2022
2021
2022
Q1: -75.2x
Med: -1.06x
Q3: 0.0x
Average

In 2022, the interest coverage of SPFPLAS PHARMACIE CLAUDE ... (-130.7x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 193 days. Excellent situation: suppliers finance 193 days of the operating cycle (retail model).

Operating WCR (2022) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2022) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2022) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

193 j

Inventory turnover (2022) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SPFPLAS PHARMACIE CLAUDE BERNARD

Positioning of SPFPLAS PHARMACIE CLAUDE BERNARD in its sector

Comparison with sector Fonds de placement et entités financières similaires

Valuation estimate

Indicative estimate only : the number of comparable transactions in this sector is limited (23 transactions). This range of 735 610€ to 2 274 979€ is provided for information purposes only and requires in-depth analysis to be confirmed.

Estimated enterprise value 2022
Indicative
735k€ 1393k€ 2274k€
1 393 894 € Range: 735 610€ - 2 274 979€
NAF 5 année 2022

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 23 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Fonds de placement et entités financières similaires)

Compare SPFPLAS PHARMACIE CLAUDE BERNARD with other companies in the same sector:

Voir toutes les statistiques du secteur Fonds de placement et entités financières similaires

Frequently asked questions about SPFPLAS PHARMACIE CLAUDE BERNARD

What is the revenue of SPFPLAS PHARMACIE CLAUDE BERNARD ?

The revenue of SPFPLAS PHARMACIE CLAUDE BERNARD is not publicly disclosed (confidential accounts filed with INPI).

Is SPFPLAS PHARMACIE CLAUDE BERNARD profitable?

Yes, SPFPLAS PHARMACIE CLAUDE BERNARD generated a net profit of 98 k€ in 2022.

Where is the headquarters of SPFPLAS PHARMACIE CLAUDE BERNARD ?

The headquarters of SPFPLAS PHARMACIE CLAUDE BERNARD is located in PARIS (75019), in the department Paris.

Where to find the tax return of SPFPLAS PHARMACIE CLAUDE BERNARD ?

The tax return of SPFPLAS PHARMACIE CLAUDE BERNARD is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SPFPLAS PHARMACIE CLAUDE BERNARD operate?

SPFPLAS PHARMACIE CLAUDE BERNARD operates in the sector Fonds de placement et entités financières similaires (NAF code 64.30Z). See the 'Sector positioning' section above to compare the company with its competitors.